Heart Disease Clinical Trials in Nashville

Showing 181-200 of 246 trials

Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study)

NCT00911703

The purpose of this study is to determine if certain findings (blood tests, symptom improvement, etc.) after acute heart failure treatment can identify a group of patients who are safe for early hospital discharge.

Acute Heart Failure

Vanderbilt University835 participantsStarted Aug 2008

Cincinnati, Ohio, United States • Nashville, Tennessee, United States

COMPLETEDPHASE1< 1 mile

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure

NCT01258387

Study to determine the safety, tolerability, pharmacokinetics and immunogenicity of single intravenous administrations of GGF2 in patients with heart failure.

Heart Failure

Acorda Therapeutics40 participantsStarted Dec 2010

Atlanta, Georgia, United States • Nashville, Tennessee, United States

COMPLETEDPHASE2100 miles

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

NCT01245634

This randomized double-blind, placebo-controlled study will evaluate the efficacy and safety of RO4905417 in the prevention of saphenous vein graft disease in patients undergoing elective or urgent coronary artery bypass (CABG) surgery. Patients will be randomized to receive either RO4905417 20 mg/kg by intravenous infusion or placebo every 4 weeks for 32 weeks.

Coronary Heart Disease, Graft Occlusion, Vascular

Hoffmann-La Roche384 participantsStarted Dec 2010

Huntsville, Alabama, United States • Tucson, Arizona, United States • Los Angeles, California, United States +35 more locations

Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study)

Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Heart Disease Trials in Other Cities

Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

TAXUS Libertē Post Approval Study

Evaluation of Vepoloxamer in Chronic Heart Failure

Niacin Plus Statin to Prevent Vascular Events

A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

Get Going: Accelerometer-Based Intervention to Promote Physical Activity in Frail Older Adults

GORE Flow Reversal System and GORE Embolic Filter Extension Study

A Pharmacodynamic Study With Ticagrelor in African American Patients

Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study)

Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality

Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement

A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

Radial Artery Access With Ultrasound Trial

Other Conditions in Nashville